Overview

Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study will explore the utility of magnetic resonance imaging (MRI) to assess ventilatory defects that occur due to asthma, determine the sensitivity and specificity of MRI in response to drug treatment, and whether MRI can serve as a biomarker of treatment effects due to asthma therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Hal C Charles
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast
Prednisone